Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial

Bibliographic Details
Title: Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial
Authors: Thiruvengadam, Swetha Kambhampati, Fakhri, Bita, Ai, Weiyun Z., Kaplan, Lawrence D., Tuscano, Joseph M., Wieduwilt, Matthew J., Sudhindra, Akshay, Cavallone, Erika, Reiner, Jesika, Aoun, Charlie, Castillo, Miguel, Martinelli, Michelle, Ta, Teresa, Le, Diem, Padilla, Michelle, Crawford, Erika, Andreadis, Charalambos B.
Source: In Clinical Lymphoma, Myeloma and Leukemia March 2021 21(3):139-146
Database: ScienceDirect
More Details
ISSN:21522650
DOI:10.1016/j.clml.2020.12.020
Published in:Clinical Lymphoma, Myeloma and Leukemia
Language:English